- Home
- REPL vs SVM Comparison
REPL vs SVM Comparison
Compare REPL & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- SVM
- Stock Information
- Founded
- REPL 2015
- SVM N/A
- Country
- REPL United States
- SVM Canada
- Employees
- REPL 331
- SVM N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- REPL Health Care
- SVM Basic Materials
- Exchange
- REPL Nasdaq
- SVM Nasdaq
- Market Cap
- REPL 1.1B
- SVM 663.6M
- IPO Year
- REPL 2018
- SVM N/A
- Fundamental
- Price
- REPL $13.98
- SVM $3.61
- Analyst Decision
- REPL Strong Buy
- SVM Strong Buy
- Analyst Count
- REPL 6
- SVM 1
- Target Price
- REPL $19.83
- SVM $5.10
- AVG Volume (30 Days)
- REPL 610.9K
- SVM 6.0M
- Earning Date
- REPL 02-12-2025
- SVM 02-11-2025
- Dividend Yield
- REPL N/A
- SVM 0.70%
- EPS Growth
- REPL N/A
- SVM 104.66
- EPS
- REPL N/A
- SVM 0.36
- Revenue
- REPL N/A
- SVM $266,463,000.00
- Revenue This Year
- REPL N/A
- SVM $35.91
- Revenue Next Year
- REPL $1,065.54
- SVM $9.60
- P/E Ratio
- REPL N/A
- SVM $10.02
- Revenue Growth
- REPL N/A
- SVM 28.94
- 52 Week Low
- REPL $4.92
- SVM $2.34
- 52 Week High
- REPL $17.00
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- REPL 55.54
- SVM 63.01
- Support Level
- REPL $13.40
- SVM $3.57
- Resistance Level
- REPL $14.59
- SVM $3.76
- Average True Range (ATR)
- REPL 0.84
- SVM 0.16
- MACD
- REPL -0.02
- SVM 0.04
- Stochastic Oscillator
- REPL 66.52
- SVM 70.46
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.